UnitedHealth Group stands out as a solid investment choice amidst financial uncertainty. With an equity beta of 0.67, it offers a stable investment with growth potential. The company, driven by ...

Journal’s spring Aging Wellness Expo returns Saturday at South Point hotel-casino. The Aging Wellness Expo, Nevada’s largest ...

A colonoscopy can help detect colorectal cancer early, greatly improving your prognosis. Sponsored by Optum Care Washington.

"Discover the top five major ASC deals making waves in the industry, including private equity acquisitions and strategic partnerships, as healthcare organizatio ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

His parents have now filed a lawsuit against both the pharmacy benefits-management company and Walgreens, claiming they are responsible for their son's death. The Schmidtknechts' ...

We recently published a list of 10 Most Undervalued High Quality Stocks to Buy According to Analysts. In this article, we are ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...